Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

YuHan Wei

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Journal of Medicinal Chemistry|June 16, 2022
Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)Xue Yuan, Yong Chen, Minghai Tang, et al.
Scientific Reports|November 20, 2025
Optimized design and experiment of a controllable rotary tube strip fertilizer spreader for hilly mountainous terrainGuoqiang Dun, Shang Gao, Xinxin Ji, et al.
Nature Medicine|July 5, 2024
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trialHongnan Mo, Yongpei Yu, Xiaoying Sun, et al.
Acta Pharmaceutica Sinica. B|July 23, 2025
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injuryYong Chen, Xue Yuan, Wei Yan, et al.
International Journal of Surgery (London, England)|March 20, 2024
An anti-infection and biodegradable TFRD-loaded porous scaffold promotes bone regeneration in segmental bone defects: experimental studiesHaixiong Lin, Zige Li, Zhenze Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2024
ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcsZhiyuan Xiang, Guixue Hou, Shanliang Zheng, et al.
Signal Transduction and Targeted Therapy|May 27, 2026
LISS enables immune evasion of colorectal cancers irrespective of MSI statusQingyu Lin, Xingwen Wang, Weixu Zhao, et al.
Frontiers in Immunology|July 25, 2022
Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor ProgressionYuhan Wei, Jianwei Zhang, Xueke Fan, et al.
Nature Communications|September 15, 2022
Inhibition of UBA6 by inosine augments tumour immunogenicity and responsesLei Zhang, Li Jiang, Liang Yu, et al.
Communications Medicine|March 30, 2026
Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patientsHewei Ge, Qiao Liu, Junying Xie, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Medicinal Chemistry|June 16, 2022
Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)Xue Yuan, Yong Chen, Minghai Tang, et al.
Scientific Reports|November 20, 2025
Optimized design and experiment of a controllable rotary tube strip fertilizer spreader for hilly mountainous terrainGuoqiang Dun, Shang Gao, Xinxin Ji, et al.
Nature Medicine|July 5, 2024
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trialHongnan Mo, Yongpei Yu, Xiaoying Sun, et al.
Acta Pharmaceutica Sinica. B|July 23, 2025
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injuryYong Chen, Xue Yuan, Wei Yan, et al.
International Journal of Surgery (London, England)|March 20, 2024
An anti-infection and biodegradable TFRD-loaded porous scaffold promotes bone regeneration in segmental bone defects: experimental studiesHaixiong Lin, Zige Li, Zhenze Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2024
ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcsZhiyuan Xiang, Guixue Hou, Shanliang Zheng, et al.
Signal Transduction and Targeted Therapy|May 27, 2026
LISS enables immune evasion of colorectal cancers irrespective of MSI statusQingyu Lin, Xingwen Wang, Weixu Zhao, et al.
Frontiers in Immunology|July 25, 2022
Immune Profiling in Gastric Cancer Reveals the Dynamic Landscape of Immune Signature Underlying Tumor ProgressionYuhan Wei, Jianwei Zhang, Xueke Fan, et al.
Nature Communications|September 15, 2022
Inhibition of UBA6 by inosine augments tumour immunogenicity and responsesLei Zhang, Li Jiang, Liang Yu, et al.
Communications Medicine|March 30, 2026
Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patientsHewei Ge, Qiao Liu, Junying Xie, et al.
Pageof 8